Prof @Rayazamalik team @OfficialUoM🇬🇧 @WCMQatar🇶🇦 tweets about research on corneal confocal microscopy #CCM👁️ a #biomarker for #neurodegenerative diseases
Doha, Qatar & Manchester, UK
Joined August 2014
- Tweets399
- Following1.8K
- Followers2.1K
- Likes453
ENA Group 👁️ retweeted
WCM-Q clinician scientist @Rayazamalik ranked number one medical researcher in #Qatar for third year running. Congratulations 🥇
@TheLancet @QF @Cornell @WeillCornell @WCMQresearch @CornellRsrch
qatar-weill.cornell.edu/medi…
ENA Group 👁️ retweeted
Read the full study here: onlinelibrary.wiley.com/doi/…
ENA Group 👁️ retweeted
Our intuition often misleads us into thinking that general obesity carries the same risk as central obesity. Our study shows that visceral, not subcutaneous, fat drives peripheral #neuropathy through diabetes, hypertension, inflammation, and vascular disease.
X was once a valuable platform for exchanging ideas. However, with the amplification of misinformation, messages getting buried, and the owner’s retweeting of false content, it is no longer a platform for meaningful conversations.
ENA Group 👁️ retweeted
Our latest research on CCM shows that corneal endothelial cell density is significantly reduced in dementia and is associated with cortical gray matter atrophy, while corneal nerve fiber loss is evident in both mild cognitive impairment and dementia. alz-journals.onlinelibrary.w…
As AI advances in the analysis of corneal nerve morphology, @Yiannaras et al., from Prof. @Rayazamalik's lab, showed that corneal confocal microscopy (CCM) can distinguish patterns of neurodegeneration in multiple sclerosis and epilepsy. Read more: pubmed.ncbi.nlm.nih.gov/3967…
ENA Group 👁️ retweeted
Ioannis N. Petropoulos et al. @Yiannaras @GroupENA @WCMQresearch report that Corneal Confocal Microscopy Identifies and Differentiates Patients With Multiple Sclerosis and Epilepsy, tvst.arvojournals.org/articl….
ENA Group 👁️ retweeted
Pleasure to present on neuropathy in prediabetes & diabetes at the 29th TMIMS international symposium: a new era for diagnosis and treatment of #diabetic_neuropathy at the Tokyo Metropolitan Institute of Medical Science. Thank you Dr Odriozola & Dr Sango for the kind invitation!
ENA Group 👁️ retweeted
Weight management in diabetes: study highlights neuroprotective role of weight loss medications
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 149th NEUROdiab Publication News is by Mette Krabsmark Borbjerg (neurodiab.eu/publication-new……)
ENA Group 👁️ retweeted
Did you know diabetic neuropathy affects millions of people, leading to distressing complications which affect well-being? This @WorldDiabetesDay, @NEUROdiab_eu Youth Committee is working to improve well-being & reduce the impact of #neuropathy. Together, we can make a difference
ENA Group 👁️ retweeted
Honored to celebrate 10 years at Weill Cornell Medicine-Qatar! Proud to contribute to CCM research on neurological disorders with Prof. Malik's team and mentor medical students through the AOC program. Grateful for the journey and the impact we've made together!
ENA Group 👁️ retweeted
Choosing diabetes medications that promote weight loss may help reduce nerve damage, improve long-term outcomes for patients. Weight management is crucial in diabetes care.
ENA Group 👁️ retweeted
Their study found that people with type 2 diabetes on medications that cause weight gain had worse nerve damage and a greater loss of corneal nerves over time compared to those on weight loss medications.
ENA Group 👁️ retweeted
Obesity is a major risk factor for diabetic peripheral neuropathy (DPN) in type 2 diabetes. This study investigated the effect of glucose lowering medication associated with weight change on DPN.
ENA Group 👁️ retweeted
Check out the new work from @GPonirakis and colleagues:
Glucose lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes
onlinelibrary.wiley.com/doi/…
#JPNSXHighlights
ENA Group 👁️ retweeted
Thank you, all, for a truly great #NeuroDiab2024
🇩🇰🇮🇹
@GPonirakis @Yiannaras @Rayazamalik @johanroeikjer @KenderZoltan @VinniRasmussen @MSjoegaard @MetteBorbjerg
ENA Group 👁️ retweeted
FCS leads to small fibre nerve damage, clinical neuropathy & early CAN
@Neurodiab_eu
@heartukcharity
@CVD_MFT
@RareDiseases
@CheckOrphan – at Rome, Lazio
ENA Group 👁️ retweeted
Great work by @GPonirakis from Rayaz Malik group showing the variables associated with large and small fibre #neuropathy in people with and without T2 #diabetes . It highlights the links between visceral #obesity and health beyond BMI @Neurodiab_eu #neurodiab2024
ENA Group 👁️ retweeted
Professor @Rayazamalik and Dr @Yiannaras, @GroupENA, discuss their work on a new, non-invasive, inexpensive way of detecting early stages of #neurodegeneration that could be as easy as an #opticians appointment.
DOI: bit.ly/3MJ4rgF
Listen: buzzsprout.com/582022/156555…
ENA Group 👁️ retweeted
Could an eye camera be a game-changer in the diagnosis of neurodegenerative diseases? 🧠🔬
We think yes!
In this podcast, we argue that corneal confocal microscopy makes sense as a biomarker and look into the future.
Shout out to the team @ResearchpodHQ for hosting us 👏🫡
